Study on the effect of pain medication on functional capacity and self reported disability in patients with chronic low back pain; a triple blinded RCT - Pain medication and functional capacity in chronic low back pain

niversitair Medisch Centrum Groningen0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年5月13日

适应症

试验速览

暂无简介。

•Non-specific low back pain with a VAS score >= 40mm, pain lasting longer than 3 months, age older than 18 years, and motivated for multidisciplinary rehabilitation. Patients are informed about the study and have signed informed consent form.

•Mental (for example major psychiatric disorders) or physical causes (for example cardiac or pulmonary problems) for reduction in functioning; hypertension; unable/unsafe to participate in Functional Capacity Evaluation (FCE); contra-indication for use of prescribed medication (use of MAO inhibitors, use of SSRI*s, known liver and renal function problems, epilepsy, brain damage, COPD, pregnancy); use of opioids; not willing to stop other treatments for CLBP (physiotherapy, manual therapy etc.). Patients will also be excluded if they had previously discontinued paracetamol/tramadol therapy due to adverse effects.

发起方